Home > Healthcare > Biotechnology > Biotechnology R&D > Gene Expression Market

Gene Expression Market Trends

Report ID: GMI8370
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Gene Expression Market Trends

The growing adoption of personalized medicine is driving significant growth in the gene expression industry. Gene expression analysis plays a crucial role in personalized medicine by providing insights into the molecular mechanisms underlying diseases and helping identify specific biomarkers for diagnosis, prognosis, and treatment response prediction.

Furthermore, as personalized medicine continues to gain traction in clinical practice, the demand for gene expression analysis tools and services is expected to grow substantially, thereby driving the expansion of the market.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of gene expression reached USD 12.5 billion in 2023 and is set to witness 7.1% CAGR from 2024 to 2032, led by technological advancements and a growing emphasis on personalized medicine.

The consumables segment accounted for 46.9% of the market share in 2023, owing to its steady and regular use in gene expression experiments which are typically tailored to specific techniques or platforms.

North America market is set to exhibit robust growth between 2024 and 2032, attributed to the increased funding from government agencies, private investors, and pharmaceutical companies in the region.

Some prominent firms operating in the market are Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., GE HealthCare Technologies, Inc., Illumina, Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California, Inc., PerkinElmer, Inc., Promega Corporation, Qiagen N.V., and Thermo Fisher Scientific Inc.